Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to evaluate the safety and efficacy of a therapeutic DNA vaccine in adults with symptomatic herpes simplex virus type 2 (i.e., genital herpes).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vical
NCT04950712 · Herpes Genitalis
NCT00486200 · Herpes Genitalis
NCT02852876 · Herpes Genitalis, Herpes Zoster
NCT00405821 · HIV Infections, Herpes Genitalis
NCT00076232 · HIV Infections, HIV Seronegativity, and more
Alabama Vaccine Research Clinic at University of Alabama at Birmingham
Birmingham, Alabama
Medical Center for Clinical Research
San Diego, California
QPS Broward Research
Hollywood, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions